{
    "id": 13124,
    "fullName": "SLC45A3 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SLC45A3-BRAF results from the fusion of SLC45A3 and BRAF, is transforming in cell culture and promotes tumor growth in mouse models (PMID: 20526349). SLC45A3-BRAF has been identified in prostate cancer (PMID: 20526349).",
            "references": [
                {
                    "id": 3753,
                    "pubMedId": 20526349,
                    "title": "Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20526349"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 85414,
        "geneSymbol": "SLC45A3",
        "terms": [
            "SLC45A3",
            "IPCA-2",
            "IPCA-6",
            "IPCA-8",
            "IPCA6",
            "PCANAP2",
            "PCANAP6",
            "PCANAP8",
            "PRST"
        ]
    },
    "variant": "SLC45A3 - BRAF",
    "createDate": "10/13/2015",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 3515,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human prostate cells expressing SLC45A3-BRAF were sensitive to Nexavar (sorafenib), resulting in decreased cell proliferation (PMID: 20526349).",
            "molecularProfile": {
                "id": 13288,
                "profileName": "SLC45A3 - BRAF"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3753,
                    "pubMedId": 20526349,
                    "title": "Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20526349"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 3519,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human prostate cells expressing SLC45A3-BRAF were sensitive to U0126, resulting in decreased cell proliferation and invasion (PMID: 20526349).",
            "molecularProfile": {
                "id": 13288,
                "profileName": "SLC45A3 - BRAF"
            },
            "therapy": {
                "id": 2427,
                "therapyName": "U0126",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3753,
                    "pubMedId": 20526349,
                    "title": "Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20526349"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13288,
            "profileName": "SLC45A3 - BRAF",
            "profileTreatmentApproaches": [
                {
                    "id": 6983,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "SLC45A3 - BRAF"
                },
                {
                    "id": 6982,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "SLC45A3 - BRAF"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}